This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Buck Institute for Research on Aging, Napa Therapeutics Limited. Active years: 2025.
Company Filing History:
1 out of 51 
1 out of 1 Years Active: 2025
Title: The Innovations of Frederick R. Nelson
Introduction
Frederick R. Nelson is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for various diseases. His work has led to the creation of a patent that showcases his innovative approach to medical treatment.
Latest Patents
One of Frederick R. Nelson's key patents is titled "Heteroaryl amide inhibitors of CD38." This patent discloses heteroaryl amide inhibitors of CD38 and outlines methods for making and using these compounds in the treatment of diseases and disorders. His innovative work in this area has the potential to impact therapeutic strategies significantly.
Career Highlights
Throughout his career, Frederick R. Nelson has worked with various organizations, including Napa Therapeutics Limited and the Buck Institute for Research on Aging. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Frederick R. Nelson has collaborated with notable individuals such as Robert A. Volkmann and Jotham W. Coe. These partnerships have further enhanced his research and development efforts, leading to advancements in the understanding of CD38 inhibitors.
Conclusion
Frederick R. Nelson's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an innovative inventor. His work continues to pave the way for new treatments and advancements in medical science.